The Group's principal activities are researching, developing, manufacturing, marketing and distributing biopharmaceutical and allied products. It operates through the following segments: CSL Behring and other human health. CSL Behring includes manufacturing, marketing and developing plasma products. Other human health includes CSL Bioplasma and CSL Biotherapies. Other activity includes intellectual property licensing. Activities are carried out in Australia, the United States of America, Switzerland and German.
Alacra Alerts:
Receive alerts on the latest reports on CSL Ltd.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
